News
Low androgen in kidney recipients tied to diabetes
A fourfold increased risk was seen for highest versus lowest tertiles of both dihydrotestosterone and testosterone in male kidney transplant...
News
Expensive insulins, pen devices dominate U.S. diabetes care
Analog insulins continue to represent more than 80% of prescriptions for type 2 diabetes in the U.S., despite rising costs and public scrutiny of...
News
‘Push the bar higher’: New statement on type 1 diabetes in adults
“The focus on adults is kind of new and it is important. ... I do think it’s a bit of a forgotten population,” says coauthor Dr. M. Sue Kirkman....
News
Medtronic expands recall of MiniMed 600 insulin pumps
The company now says it will replace all pumps with clear retainer rings, not just those that appear damaged.
News
TriMaster study shows precision medicine in diabetes is possible
The novel TriMaster trial of three type 2 diabetes drug classes shows different ones work better for different patients.
News
Age, C-reactive protein predict COVID-19 death in diabetes
“This means we can easily identify patients early on in their hospital stay who will likely require more aggressive interventions to try and...
News
EASD: Precision in diabetes management and impact of COVID-19
The European Association for the Study of Diabetes annual meeting will feature precision medicine sessions, a consensus statement on type 1...
News
Type 2 diabetes ‘remission’ is a reality, say major organizations
A new consensus statement by four major diabetes organizations aims to standardize the definition and assessment of type 2 diabetes ‘remission.’...
News
Emerging data point to underlying autoimmunity in ME/CFS
Findings suggest that potential treatments targeting autoantibodies may alleviate symptoms.
News
New recommendations address ME/CFS diagnosis and management
Document is based on expert clinician experience in illness that has long been overlooked and inappropriately managed.
News
FDA approves rapid-acting insulin, Lyumjev, for pump use
Approved for diabetes treatment last year, it’s the second ultra-rapid-acting insulin approved for use in insulin delivery devices.
News
Half abandon metformin within a year of diabetes diagnosis
Multiple factors are blamed for the drop-off, while improved communication, follow-up, and medication adjustment are advised as remedies.
News
FDA clears app for FreeStyle Libre 2 glucose monitor
System includes optional alarms; app allows for remote monitoring.
News
‘Shocking’ early complications from teen-onset type 2 diabetes
Almost two-thirds of study participants had at least one diabetes complication in young adulthood, around 15 years after diagnosis. A handful died...